Indications: Cervical Spondylotic Myelopathy and OPLL. Cervical laminoplasty is recommended in the treatment of myelopathy in the setting of CSM or OPLL. Using the JOA scale, ~ 55-60% recovery rate is anticipat ed (quality of evidence, Class III; strength of recommen dation, D). The functional improvement observed after laminoplasty may be limited by duration of symptoms, severity of stenosis, severity of myelopathy, and poorly controlled diabetes as risk factors. There is conflicting evidence regarding age with 1 study citing age as a risk factor, and another not demonstrating this result (quality of evidence Class II). Object. The objective of this systematic review was to use evidence-based medicine to examine the efficacy of cervical laminoplasty in the treatment of cervical spondylotic myelopathy (CSM).
and laminectomy with arthrodesis. Evidence is unclear regarding differences in complication rates between these techniques (quality of evidence, Class III; strength of rec ommendation, D).
Timing. There is insufficient evidence to make a rec ommendation regarding timing of surgery.
Rationale
The purpose of this review is to examine questions regarding the efficacy of laminoplasty using an evidencebased approach. Cervical laminoplasty was described in the 1970s as an alternative to laminectomy in patients with myelopathy. 10 The impetus for laminoplasty was the desire to decompress long segments while avoiding postlaminectomy membrane formation and/or kyphotic deformity. 10 The authors of multiple reports have dem onstrated that laminoplasty increases canal diameter. 23, 28 However, this increase in canal diameter appears to be at the expense of pain and diminished ROM. 4, 21, 30, 31, 33, 36, 39, 43 Different approaches to laminoplasty include the opendoor, the midline "Frenchwindow," and the Z plasty techniques. 10, 31 Each of these techniques permits expansion of the canal while providing a dorsal laminar cover. Specific questions regarding laminoplasty include its effectiveness in improving myelopathy, its efficacy compared to other techniques for decompression, and its complication rate. Other issues include diminished ROM, pain, and preoperative predictors of clinical outcome in patients undergoing this approach.
Search Criteria
We performed a computerized search of the National Library of Medicine database and the Cochrane database of the literature published between 1966 and 2007. We used standard keywords along with MeSH headings. A search using the subject heading "laminoplasty" yielded 381 citations. The following subject headings were com bined: "laminoplasty and outcome," "laminoplasty and cervical spine," "laminoplasty and myelopathy," "lamin oplasty and surgery," and "laminoplasty and cervical stenosis." These search terms yielded 155, 269, 266, 347, and 69 citations, respectively. Accounting for redundancy, 314 citations were acquired. We selected only citations in English, and reviewed the titles and abstracts. Additional references were culled from the reference lists of the re maining articles.
Among the studies reviewed, 46 dealt with cervical laminoplasty and outcome, including functional outcome and ROM (Table 1) . These studies also assessed compli cation rates, pain, and prognostic factors. Sixteen of these studies compared laminoplasty to a different surgical ap proach. One article was a metaanalysis review of lamin oplasty. The remaining studies examined functional im provement, especially myelopathy, using the JOA scale.
Scientific Foundation
Clinicians have used laminoplasty to treat cervical myelopathy primarily resulting from CSM or OPLL. Quantitative outcome measures for cervical myelopa thy are many. Most studies used the JOA and Nurick scales. 5, 29 The JOA scale is a reliable, valid, and respon sive measure. Although more traditional, the Nurick scale has not been studied in as great detail.
Effectiveness
Multiple studies have demonstrated the effective ness of laminoplasty within a group of patients. Using the JOA outcome scale, the average recovery for patients was 55-65%. 4, 10, 12, 21, 25, 28, 31, 33, 36, 38 None of these studies used a nonoperated control group. 31 Accordingly, the data sup porting their conclusions is Class III. In the short term, Kihara et al. 21 reported on 151 patients with myelopathy (average age of 62 years, mean symptom duration 31 months), 132 with CSM, and 19 with OPLL. Surgeries were completed over a 7month period. The mean JOA scale score increased from 8.1 to 15.2 at the 1year follow up examination (p < 0.01). Multiple other Class III studies corroborated this type of shortterm improvement. 31 Suda et al. 38 reported on 154 patients with CSM over an 18year span who underwent Frenchwindow lamin oplasty. Followup was possible in 114 patients (mean age 60 years), for an average of 5 years. The JOA scale score improved from 9.9 to 14.0 (60% improvement) in this series. To assess outcomes over a longer period of time, Seichi et al. 36 reviewed 60 patients (mean age 54.5 years; 35 with OPLL and 25 with CSM) who underwent Frenchwindow laminoplasty with 10 years of followup. In the OPLL group, the JOA scale score increased from 8.6 to 12.1; similar increases were seen in the patients with CSM (improvement from 8.3 to 12.0). Late clinical worsening was observed in 11 patients (7 with OPLL and 4 with CSM). Several other Class III studies corrobo rated clinical improvement maintained over 5 30, 33 and 10 years. 13, 18, 43 However, in their study, Ogawa and col leagues 30 noted functional decline as evidenced by lower JOA scale scores 5 years after laminoplasty.
Prognosis
Any discussion regarding efficacy should be tem pered by a discussion of prognosis because there likely exist patients who are not going to benefit. Conventional wisdom would argue that increasing age would be a risk factor, but laminoplasty studies have produced conflicting results. The authors of some studies have reported age to be a risk factor, 18, 23, 35, 45 while others did not come to the same conclusions. 6, 17, 40, 45, 46 Kohno et al. 23 examined 22 patients (mean age 60 years) with myelopathy (CSM in 12 and OPLL in 5) who underwent Frenchwindow lamino plasty and participated in followup for 5 years. The aver age JOA scale score recovery was 51% of the maximum.
In their study of 61 consecutive patients, Handa et al. 6 reported results indicating that increased age was not a risk factor. Patients were stratified into those older than 70 years of age (22 patients, mean age 74 years) and those younger (39 patients, mean age 57 years). Postop erative evaluation at 1 year after opendoor laminoplasty revealed recovery rates of 59% in the younger and 62% in older group. This study was graded Class II because patients were studied as a cohort and all were eligible for the same treatment. Yamazaki et al. 46 took a differ ent approach in their study of 64 patients with CSM who underwent Frenchwindow laminoplasty. The authors stratified groups into those younger than 65 years (29 pa tients with a mean age of 53 years) and those older (35 patients with a mean age of 79 years). Evaluation took place over 3.5 years. In the younger group, the JOA scale score improved from 14.8 to 15.8 (62% recovery). In the older group, the JOA scale score improved from 12.0 to 14.6 (59% recovery). There was a significant difference between final JOA scale scores (15.8 vs 14.6; p < 0.05) but not recovery (62 vs 59%; p = 0.758). This study was rated Class III because the starting JOA scale score in the younger group was significantly higher than in the older group. This bias invalidated the comparison.
Less controversial were evaluation of duration and se verity of symptoms. The studies undertaken by Yamazaki et al. 46 (rated Class III) and Handa et al. 6 (rated Class II) examined severity (mean transverse area at maximum compression and canal diameter) and duration of symp toms. Both groups found that symptom durations longer than 12 months portended a better outcome in elderly pa tients. Yamazaki and colleagues 46 also concluded that a smaller mean transverse area negatively affected all pa tients; however, in the study by Handa et al., 6 more severe stenosis impaired outcome only in elderly patients.
Three Class II studies associated lower JOA scale scores with a worse outcome. In the study of Handa et al., 6 outcome relative to preoperative JOA scale scores was evaluated in the young and the elderly. A JOA scale score < 12 was associated with a worse outcome, but only in patients younger than 70 years of age. Iwasaki et al. 13 studied 92 patients with OPLL who underwent opendoor laminoplasty over an 8year period. Only 64 patients were evaluated because the minimum followup was 10 years (25 patients died and 3 were lost to followup). Al though the JOA scale score improved from 8.9 to 13.8, a low JOA scale score carried a strong negative prognosis (p < 0.0001). The patients who died also had a mean pre operative JOA scale score of 6.9-confirming the poor prognosis associated with severe myelopathy. 13 Kamizono et al. 15 reviewed 301 patients with OPLL who underwent opendoor laminoplasty (mean age 58 years, 8year fol lowup period). The pre and postoperative JOA scale scores were evaluated along with symptom duration and exertion required by the patient's job. A JOA scale score < 9, either pre or postoperatively, was negatively associ ated with returntowork, as was the extent of exertion re quired by the job. Duration did not affect returntowork. This study was evaluated as Class II for prognosis.
The authors of 2 Class II studies dealt with specific prognostic issues. Kawaguchi et al. 19 studied 18 patients with CSM and OPLL who had diabetes mellitus (mean age 66 years), and underwent opendoor laminoplasty. These authors compared these 18 patients with 34 patients in a control group who underwent the same therapy but did not have diabetes mellitus. Recovery for both groups was the same according to the JOA scale score (12.6 with diabetes and 13.3 without; p = 0.25). Within the diabe tes group, the authors observed a negative correlation between JOA scale score and hemoglobin bA1c levels (r = −0.61, p < 0.03). This study was graded as Class II for prognosis. Baba et al. 1 examined posterior cord migration in 55 patients who underwent opendoor laminoplasty. The authors used an index that examined the distance from the anterior spinal canal (posterior surface of the vertebral body) to the center of the spinal cord. Using this system, the authors reported an average shift of 55.3% relative to baseline in patients whose JOA scale scores improved > 50%, and an average shift of 27.7% rela tive to baseline in patients whose JOA scale scores im proved < 50%. Matsuyama et al. 27 reported on 44 pa tients with cervical myelopathy (26 with CSM and 18 with OPLL) who underwent laminoplasty. The authors measured the crosssectional area, sagittal diameter, and transverse diameter of the spinal cord prior to surgery, immediately afterward, and 1 month postoperatively. They correlated results with JOA scale scores. Increased crosssectional area was considered "expansion." The au thors found that gradual expansion (over the course of 1 month) was associated with a 68.4% recovery rate, while a 32.6% recovery rate was seen without gradual expan sion. This study was graded Class III because observers were not necessarily blinded to preoperative JOA scale scores, and the uncertainty regarding selection bias as to who was chosen for surgery.
Wada et al. 44 discussed a series of 50 patients with CSM who underwent laminoplasty. This was part of an initial series of 85 patients. Ten patients were excluded and another 25 did not undergo postoperative imaging. These authors found that a transverse cord area < 40 mm 2 , a long duration of symptoms, and a poor anteroposterior canal ratio correlated with poor outcome. Less predictive were patient age and presence of a poor preoperative JOA scale score. Importantly, multisegmental hyperintensity on T2weighted images correlated strongly with a poor outcome (p < 0.01). This study was graded Class III due to nonblinded outcome assessment and the loss of 25 pa tients from the series.
Range of Motion and Pain
Laminoplasty has been associated with an aggregate loss of ROM. 4, 21, 30, 31, 33, 36, 43 However, diminished ROM has not always signified poor outcome. In the Class III study of Kihara et al. 21 described above, 151 patients (132 with CSM and 19 with OPLL) underwent opendoor lamino plasty over a 7month period. As stated, the mean JOA scale score improved significantly in this cohort. Simul taneously, ROM decreased from 36.9 to 29.1° (p < 0.01). Saruhashi and colleagues reviewed 30 patients who un derwent Frenchwindow laminoplasty for CSM. 33 Pa tients were followed up for 5 years, and JOA scale scores (continued) In Group B, 3/37 had C-5 palsy (p < 0.05).
III
Cl ass III due to selection bias. All C-5 palsies occurred in group selected by different surgeons. EMG evaluation appeared to help indicate which patients might benefit from foraminotomy.
(continued) improved significantly from a preoperative average of 8.8 to a postoperative average of 11.9 (p < 0.001). Simultane ously, alignment deteriorated in some (loss of 12.5°) and stabilized in others (gain of 1.1°). In comparing these 2 groups, the authors observed no significant difference in mean JOA scale scores. This study was graded as Class III due to a small series and poorly described methodol ogy. Kawaguchi and colleagues 16 described a modified laminoplasty technique used in 28 patients with a mean age of 62.7 years. The surgeons placed bone spacers at every other level, with no bone placed on the hinge side. They evaluated ROM in this cohort and compared the re sults to those achieved in 28 historical control patients who underwent standard opendoor laminoplasty (mean age 60.4 years). The followup period was 2.5 years. Range of motion was preserved 48% in the opendoor group and 71% preservation was achieved in the modi fied laminoplasty group (p < 0.02). In addition, an aver age of only 0.8 levels were fused in the modified group compared to 2.1 in the control group (p < 0.0001). This study was graded Class III because of the use of historical controls. Shiraishi et al. 37 compared skip laminectomy (in 43 patients, mean age 69 years, 32 with CSM, and 11 with OPLL) to opendoor laminoplasty (in 51 patients, mean age 67 years, 36 with CSM, and 15 with OPLL) for the treatment of cervical myelopathy. Minimum followup was 2 years, and the JOA scale recovery was similar in the 2 groups. However, ROM was 98% preserved in the skip laminectomy group compared to 44% in the lamino plasty group (p < 0.05). This study was graded Class III due to the use of historical controls.
In a Class III study, Edwards et al. 4 specifically eval uated pain in 18 patients who underwent laminoplasty by splitting of the spinous process (mean age 54 years, 2year followup). The authors assessed pain with the Robinson pain scale. Pain levels significantly decreased (2.0 to 0.9; p < 0.002). In this same group, ROM diminished signif icantly (37 to 23°; p < 0.05). Compared to a historical control group of patients who underwent laminectomy (22 patients, mean age 54 years), Kaminsky et al. 14 found that the pain level was significantly reduced (57 vs 8%, p < 0.004) with laminoplasty in 20 consecutive patients (mean age 53 years). However, this study was graded Class III because the laminoplasty group started with a significantly higher pain score than the historical control group. In a similar study, Takeuchi et al. 39 modified a C3-7 laminoplasty to preserve the C2-3 muscular attachments, and compared their results in 40 patients to 16 historical control patients. The modified laminoplasty group had significantly fewer patients with severe pain (p < 0.02). They compared this technique to C4-7 laminoplasty with undercutting of the C3 lamina. In this Class III study, the authors demonstrated no difference in clinical outcomes, but did show reduced pain and muscle atrophy with this modified technique. Hosono and colleagues 11 compared the presence of nuchal and shoulder pain in 72 patients who underwent laminoplasty versus a 26patient histori cal cohort who underwent ACF. The average age for both groups was 58 years, with a minimum 2year followup period. Nuchal or shoulder pain was present in 5 (19%) of 26 patients who underwent ACF and 43 (60%) of 72 patients who underwent laminoplasty (p < 0.05).
Complications
The most commonly described complication after laminoplasty is arm weakness due to C5 palsy. 13, 30, 35, 43, 47 Ratliff and Cooper 31 reported a cumulative incidence of 8%. Satomi et al. 35 reported on opendoor laminoplasty in 206 patients (106 with OPLL and 98 with CSM) of whom 80 were followed up for 5 years. In this Class III series, a complication rate of 7.8% was reported for arm weakness. Other authors have reported an incidence of 5-8%. 8, 13, 30, 47 Hatta and colleagues 8 compared selective lamino plasty (in 26 patients with an average age of 60 years, and a 19month followup period) to a historical control group of 25 patients who underwent the standard open door technique (mean age 62 years, 38month followup period). All patients had CSM over 2-3 levels. Recovery assessed with JOA scale scores was 66% in both groups. The authors compared the posterior cord shift between the 2 groups. In the selective laminoplasty group, poste rior shift was 1.1 mm, with 0% C5 palsy. In the standard historical control group, cord shift was 2.7 mm with 8% C5 palsy. Accordingly, posterior cord shift was associat ed with C5 palsy. 8 Through selective laminoplasty, Hatta et al. 8 reduced the incidence of C5 palsy while maintain ing a similar level of improvement in JOA scores. This study was graded Class III because of the use of historical controls.
Sasai et al. 34 reported on 111 patients who underwent laminoplasty. One group of surgeons treated 74 patients all of whom underwent preoperative EMG studies. A sec ond group of surgeons treated 37 patients who did not undergo preoperative EMG. Eleven of 74 patients with abnormal EMG results at C5 underwent prophylactic foraminotomy. In the first group, none of the patients had postoperative radiculopathy, while postoperative radicu lopathy developed in 3 patients in latter group. The au thors concluded that preoperative EMG was helpful. This study was graded Class III due to the significant selection bias between the groups. Komogata and colleagues 24 did not show a correlation between EMG abnormalities and C5 palsy. They reported on 305 patients, of whom 230 underwent foraminotomy in addition to laminoplasty. The study assessed patients with EMG preoperatively. Three of 118 patients with abnormal EMG results developed C5 palsy (3.5%) in contrast to 6 of 140 patients with normal EMG results (8.4%). These authors reported a reduced in cidence of C5 palsy in gutters that had a foraminotomy. This study was graded Class III because of obtuse entry criteria; however, the authors did demonstrate that preop erative EMG findings did not necessarily correlate with outcome. 25 Both Uematsu et al. 42 and Chiba et al. 2 examined the relationship of C5 postoperative palsy to clinical factors. In a series of 365 patients, Uematsu and colleagues 42 re ported an incidence of 5.5% for C5 palsy. These authors found the development of C5 palsy did not correlate with degree of stenosis, clinical severity of myelopathy, or the spinal curvature index. They reported that elevation of the laminae to an angle > 60° was associated with greater likelihood of C5 palsy. This study was graded Class III because of the multiple techniques used for laminoplasty. Chiba and colleagues 2 described a retrospective series of 208 patients who underwent laminoplasty. Segmental motor paralysis developed in 15 patients, in most cases at C5. Weakness developed an average of 4.6 days after surgery. Fourteen of 15 patients had severe dysesthetic pain in the hands prior to surgery, a symptom that did not improve. Magnetic resonance imaging evaluation af ter surgery showed focal hyperintensity on T2weighted images in all 15 patients with segmental motor paralysis, in contrast to an incidence of 58% in the patients without deficit. This study was graded Class III because of its ret rospective nature.
Ratliff and Cooper 31 reported a cumulative incidence of postlaminoplasty kyphosis of 10%. In their study of 92 patients with OPLL, Iwasaki et al. 13 conducted followup in 56 patients over a 10year period, and described a long term kyphosis rate of 8%. Both Saruhashi et al. 33 and Suda et al. 38 examined postoperative kyphosis and outcome. In the Saruhashi et al. 33 study described above, 30 patients with CSM underwent laminoplasty with a 5year follow up period. Patients who developed kyphosis (−12.5°) had similar clinical outcomes as those who had lordosis pre served (+1.1°). This study was graded Class III because it is a small series with poorly described methodology. Suda et al. 38 conducted followup in 114 patients with CSF for 5 years. The C2-7 angle was used to assess for preservation of lordosis. In this study, development of kyphosis and the presence of local kyphosis predicted poor outcome (p < 0.05). 38 This study was graded Class III because of the heterogeneous definition of kyphosis the authors usedsome patients began the study with loss of cervical lordo sis and could not "develop" kyphosis. In a different Class III study, Maeda et al. 26 reported followup in 30 of 44 patients who underwent laminoplasty for OPLL. The av erage patient age was 59 years, and the followup period averaged 3.2 years. The authors found that the curvature index reduced from 14.5 to 2% after laminoplasty, with ROM deteriorating from 41 to 24°. They reported a cor relation between diminished ROM, diminished curvature index, and reduced JOA scale scores. Because of the sig nificant loss of study patients, this study was graded Class III.
Kimura and colleagues 22 examined the "boomerang" deformity that occasionally developed in the spinal cord with posterior shift after split laminae laminoplasty. They reviewed 39 consecutive cases of laminoplasty (in patients with CSM, OPLL, and cervical disc herniation) for cervi cal myelopathy. The boomerang deformity developed in 8 patients with migration of the spinal cord between the split laminae. These patients were compared with 31 pa tients in whom this deformity did not develop. There were no significant differences in age, pre-and postoperative JOA scale scores, or recovery rates between patients with and without this deformity. Patients who developed the "boomerang" spinal cord deformities were significantly more likely to have had a lower flattening ratio (sagittal/ transverse diameter; p < 0.027) and/or a lower transverse diameter between the split laminae (p < 0.0003). This study was graded Class III because only 1 author com pleted the patient measurements, and it was uncertain whether that author was blinded to the patient group.
Comparison With Other Techniques
Laminoplasty was compared to ACDF in 3 studies in patients with singlelevel disc displacement and myelopa thy. 12, 32, 48 In the Class III studies by Iwasaki et al. 12 and Sakaura et al., 32 patients underwent ACF in the beginning of the study period, and laminoplasty if diagnosed more recently. In Iwasaki and colleagues' 12 study, which includ ed 17 ACDFs and 16 laminoplasties, the JOA recovery rates were 93 and 81%, respectively. The Sakaura et al. 32 study, which included 15 ACDFs and 18 laminoplasties, showed JOA score recovery rates of 71 and 70%, respec tively. In a Class III study, Yoshida et al. 48 compared 32 patients who had undergone laminoplasty with 44 patients who underwent ACDF. Unlike the laminoplasty group, however, the ACDF group did not have superimposed congenital stenosis. The JOA scale scores were similar between groups. The reported complication rate was higher with ACDF due to graft site complications. 12, 48 Laminoplasty was compared to ACF in 6 studies of treatment for CSM. 3, 7, 20, 41, 43, 47 In their Class III study, Wada et al. 43 compared subtotal corpectomy (23 patients, mean 2.5 operated levels, average age 53 years, and a 15 year followup) to opendoor laminoplasty (24 patients with an average age of 56 years, 12year followup). The JOA scale scores improved in both groups: from 7.9 to 13.4 in the corpectomy group, and from 7.4 to 12.2 in the laminoplasty group. The incidence of moderate or se vere pain was greater with laminoplasty (40 vs 15%; p < 0.05), and ROM was better preserved with corpectomy (49 vs 29%). In another Class III study, Yonenobu et al. 47 reported on 83 patients with CSM of whom 42 underwent Frenchwindow laminoplasty, and 41 underwent ACF. All had 2 years of followup, and the JOA scale scores im proved in both groups (44% with laminoplasty and 55% with ACF). Outcomes were also similar in patients with canal stenosis (< 12 mm). The complications were higher with ACF due to graft complications (29 vs 7%). However, of the 6 studies above, not all showed a higher complica tion rate for the anterior approach nor did all show better preservation of ROM with an anterior approach.
Laminoplasty was compared with a variety of pos terior techniques in several studies. In a Class III study, Kaminsky et al.
14 compared opendoor laminoplasty in 20 patients (average age 53 years) to laminectomy in 22 patients (average age 54 years) with CSM with a 3year followup. The average number of levels decompressed was 4.3 for laminoplasty and 4.6 for laminectomy. The Nurick scores improved from 2.44 to 1.48 with lamino plasty compared to 3.09 to 2.50 for laminectomy. The dif ference in recovery rates (49 vs 18%) was statistically sig nificant (p < 0.0001). However, the preoperative Nurick scores were also significantly worse for the laminectomy group (p < 0.0001). In the Class III study described above, Shiraishi et al. 37 compared the results of skip laminec tomy for the treatment of cervical myelopathy in 43 pa tients to results achieved in 51 patients who underwent opendoor laminoplasty. The JOA scale score recovery was 59% with laminectomy versus 60% with lamino plasty; however, the skip technique preserved ROM and increased the Ishiara index (from 11.4 to 13.4) compared with laminoplasty (from 16.0 to 11.8; p < 0.05).
Heller and colleagues 9 compared laminoplasty (mid line and opendoor) to laminectomy with arthrodesis in 13 patients each with CSM (mean patient age 55 years, 2year followup). Greater improvement in Nurick scores was observed with laminoplasty (from 2.3 to 1.1) com pared to laminectomy and arthrodesis (from 2.2 to 1.5), but this trend was not statistically significant. Not surpris ingly, laminoplasty was associated with greater preserva tion of ROM (p < 0.002). 9 This study was graded Class III due to significant selection bias.
Summary
Although there have been no Class I or II studies to suggest that laminoplasty is superior to nonoperative therapy for treatment of myelopathy caused by CSM or OPLL, numerous large series with longterm followup that demonstrate substantially improved neurological function when laminoplasty is used are evident. An ~ 55-60% recovery rate (JOA scale) is anticipated. Class II evi dence does suggest that duration of symptoms, severity of stenosis, severity of myelopathy, and poorly controlled di abetes are negative risk factors. There is conflicting Class II evidence regarding patient age, with 1 study citing age as a risk factor and another not demonstrating this result.
Class II evidence reveals that better JOA scale scores (both pre and postoperatively) are associated with re turning to work. Laminoplasty has been linked to re duced preservation of ROM and development of C5 pal sy. There is conflicting Class II evidence regarding the development of kyphosis and functional outcome, with 2 studies concluding a negative correlation between them.
There is no Class I or II evidence to suggest that laminoplasty is superior to other techniques for decom pression. However, Class III evidence has shown equiva lency in functional improvement between laminoplasty, ACF, and laminectomy with arthrodesis. Class III evi dence is unclear regarding differences in complication rates among these techniques.
